Organon & Co.

Organon & Co. is a global pharmaceutical company that specializes in the development and production of healthcare products and medical treatments. The company was originally established in the Netherlands in 1923 and has since grown to become a leading player in the global pharmaceutical industry.

History

Organon & Co. was founded in 1923 in Oss, the Netherlands, by Dr. Saal van Zwanenberg. The company initially focused on the production of insulin and vitamin products. Over the years, Organon & Co. has expanded its product portfolio to include a wide range of healthcare products and medical treatments.

In 2007, Organon & Co. was acquired by Schering-Plough, a US-based pharmaceutical company. Following the acquisition, Organon & Co. became a part of Schering-Plough's global pharmaceutical business. In 2009, Schering-Plough merged with Merck & Co., another US-based pharmaceutical company, and Organon & Co. became a part of the merged entity.

Products and Services

Organon & Co. offers a wide range of healthcare products and medical treatments. The company's product portfolio includes treatments for cardiovascular diseases, diabetes, respiratory diseases, oncology, and women's health. Organon & Co. is also involved in the development of biopharmaceuticals, a new class of drugs that are derived from biological sources.

Research and Development

Organon & Co. has a strong focus on research and development (R&D). The company invests heavily in R&D to develop new healthcare products and medical treatments. Organon & Co.'s R&D activities are guided by its commitment to improving patient health and well-being.

See Also

• Pharmaceutical industry
• Schering-Plough
• Merck & Co.

   This article is a pharmacology-related stub. You can help WikiMD by expanding it!